期刊文献+

护理干预与提高临床药物试验质量的相关性研究 被引量:10

Influence of nursing intervention on improvement of quality of clinical trial of drugs
下载PDF
导出
摘要 目的通过护理干预,提高慢性乙型肝炎抗病毒治疗的临床药物试验受试者的依从性,从而提高肝病临床药物试验的质量。方法将84例患有慢性乙型肝炎且符合参加阿德福韦抗病毒治疗的临床试验的志愿受试者随机分为实验组和对照组,每组各42例。对照组按照临床药物试验管理规范进行,实验组实施一系列护理干预,分别对两组受试者在试验结束后进行遵循医嘱行为调查。结果(1)实验组有1例受试者退出试验,对照组有2例受试者退出试验。(2)实验组有37例能完全遵循医嘱,占88.10%,对照组有27例能完全遵循医嘱,占64.29%,两组遵循医嘱程度的差异有统计学意义(P<0.05)。结论护理干预可明显提高临床药物试验受试者治疗的依从性,从而保证临床药物试验的质量。 Objective Through nursing intervention,to improve antiviral treatment compliance of subjects with chronic hepatitis B,and to enhance the quality of clinical drug trial. Methods Eighty-four cases of chronic hepatitis B using adefovir were randomly divided into experimental and control groups respectively, each 42 cases. Both groups were treated through the basic principle of GCP. In the experimental group a series of nursing interventions were used. The subjects' compliance behaviors during the trial were analyzed at the end of the research. Results There was a patient withdrawing from the research in the experimental group and two patients in the control group. There were 37 patients in the experimental group showing complete medical compliance (88.10%) and 27 cases (64.29%) in the control group. The difference of medical compliance between those two groups was statistically significant (P〈0.05). Conclusion Nursing intervention can significantly improve the medical compliance of subjects with chronic hepatitis B and ensure the quality of clinical drug trials.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第2期134-135,共2页 Chongqing medicine
基金 重庆医科大学附属第二医院护理骨干科研资助项目(2007)
关键词 慢性乙型肝炎 护理干预 依从性 质量 chronic hepatitis nursing intervention medical compliance quality
  • 相关文献

参考文献6

二级参考文献28

  • 1周达生,姚华庭.医学系统工程与遵医行为研究[J].中国医院管理,1995,15(2):37-39. 被引量:583
  • 2戴志澄 祁国明 等.乙肝病毒性肝炎的流行特征,中国病毒性肝炎血清流行病学调查1992-1995[M].北京:科学技术文献出版社,1997.39-59.
  • 3[5]罗和享主编.乙型病毒性肝炎[M].北京:中国医药科技出版社,2003.1~2.
  • 4Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
  • 5Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
  • 6Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
  • 7Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
  • 8刘树芝 鲍晓玲 王云玲.家庭干预在消化性溃疡病人康复中的作用[J].护理研究,2003,17(10):1193-1193.
  • 9陈从新.乙型病毒性肝炎慢性化中内外因素的相互作用 [J].医学与哲学,1988,9:42-42.
  • 10Diepolder HM;Jung MC;Keller E.A vigorous virus-specific CD-4 T cell response may contribute to the association of HLADR13 with viral clearance in hepatitis B[J],1998.

共引文献14105

同被引文献63

引证文献10

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部